PHARMACY

FDA approves generic antidepressant, anti-smoking drugs

BY Alaric DeArment

NOIDA, India — The Food and Drug Administration has approved drugs for depression and smoking cessation made by Jubilant Life Sciences, the company said.

Jubilant, based in India, announced the approval of generic bupropion hydrochloride extended-release tablets in the 100-mg, 150-mg and 200-mg strengths, and another bupropion hydrochloride extended-release tablet product in the 150-mg strength.

The first product is a generic version of GlaxoSmithKline’s antidepressant Wellbutrin SR, while the second is a version of GSK’s anti-smoking drug Zyban.

The total sales of the products per year are $518 million, according to IMS Health. Jubiliant will launch them next year.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Teva’s Pliva division increases manufacturing capacity by more than 25%

BY Alaric DeArment

ZAGREB, Croatia — Teva Pharmaceutical Industries is investing more than $100 million in its Croatian division for a plant that will make pills mostly for the international market.

Teva subsidiary Pliva said the new plant, in the capital of Zagreb, would considerably increase its production capacities for tablets and capsules. The company said the new plant would increase the annual manufacturing capacity by more than 25%.

"This year has been especially important for us — we are about to complete one of the largest investment cycles in the company’s history," Pliva management board president Tihomir Orešković said. "I am glad that Teva is today one of the biggest private investors in Croatia and that its investments in the production facilities in Zagreb and Savski Marof total more than $200 million."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Reports: Pa. bill to create prescription drug database passes House

BY Alaric DeArment

NEW YORK — The state Senate of Pennsylvania will vote on a bill to curb misuse of prescription drugs, according to published reports.

The Beaver County, Pa., Times reported that Pennsylvania House Bill 1694 cleared the lower house of the state legislature in a 191-7 vote. The bill is designed to stop doctor-shopping and pill mills by creating an electronic prescription drug database to track drugs dispensed by doctors and veterinarians. Doctors and pharmacists can then use it to verify patients’ medication histories.

According to a recent survey by Trust for America’s Health, Pennsylvania ranks 14th in the nation in drug overdose deaths, with 15.3 deaths per 100,000 people in 2010.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

K.JACOB says:
Oct-30-2013 07:58 am

This is wonderful. I only hope it will be connected from state to state because I know that some abusers travel quite far between Pennsylvania and New Jersey for their drugs. New Jersey has had this system for almost a year now.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?